Efficacy Claim Evaluation Focus: New Cosmetic Compliance Requirements under China\’s CSAR
May. 30th, 2022
203
Background
To help cosmetic stakeholders better understand this new compliance requirement, ChemLinked organized this webinar to detail key regulatory points focusing on efficacy claim evaluation, and also introduce the current industry status under the new requirement.
Further Reading
- News | CSAR Subsidiary Regulations: China Finalizes Standards for Cosmetic Efficacy Claim Evaluation
- News | CSAR Subsidiary Regulations: China Unveils the Cosmetic Classification Rules and Catalogs
- News | China NMPA Extends the Submission Deadline of Certain Cosmetic Documents due to COVID-19 Lockdown
- English Translation | Cosmetic Classification Rules and Catalogs
- English Translation | Standards for Cosmetic Efficacy Claim Evaluation
Contents
2.1 Classification of Claims
2.2 Prohibited Claims
3. Efficacy Claim Evaluation
3.1 Applicable Claims
3.2 Evaluation Basis
3.3 Evaluation Report and Abstract
3.4 Transitional Measures
4. Industry Status
5. Q&A
*The final outline may be subjected to subtle revision
Schedule
Date | Time (GMT+8) | World Clock | Language |
2022-06-28 | 21:30 ~ 22:30 | London: 14:30-15:30 New York: 09:30-10:30 | English |
Speaker
ChemLinked Regulatory Analyst
Jarius is a cosmetic regulatory analyst in the ChemLinked team. She focuses on tracking and interpreting the latest cosmetic regulatory changes in China, Singapore, Philippines, and the rest of the Asia Pacific area.
Contact Us
If you have any questions about this webinar, please contact us at:
EMAIL: contact@chemlinked.com
TEL: +86 (0) 571 8609 4444